PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
Anagenics Limited (AN1.AX)
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility
Financials

Company Info

ISINAU0000198095
SectorConsumer Defensive
IndustryHousehold & Personal Products

Highlights

Market CapA$3.69M
EPS (TTM)-A$0.02
Total Revenue (TTM)A$13.92M
Gross Profit (TTM)A$5.19M
EBITDA (TTM)-A$3.68M
Year RangeA$0.01 - A$0.03

Share Price Chart


Loading data...

Compare to other instruments

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Performance

Performance Chart

The chart shows the growth of an initial investment of A$10,000 in Anagenics Limited, comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.


-50.00%-40.00%-30.00%-20.00%-10.00%0.00%10.00%AprilMayJuneJulyAugustSeptember
-40.54%
5.18%
AN1.AX (Anagenics Limited)
Benchmark (^GSPC)

Returns By Period

Anagenics Limited had a return of -57.89% year-to-date (YTD) and -60.00% in the last 12 months. Over the past 10 years, Anagenics Limited had an annualized return of -37.89%, while the S&P 500 had an annualized return of 10.88%, indicating that Anagenics Limited did not perform as well as the benchmark.


PeriodReturnBenchmark
Year-To-Date-57.89%18.13%
1 month14.29%1.45%
6 months-38.46%8.81%
1 year-60.00%26.52%
5 years (annualized)-54.69%13.43%
10 years (annualized)-37.89%10.88%

Monthly Returns

The table below presents the monthly returns of AN1.AX, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.


JanFebMarAprMayJunJulAugSepOctNovDecTotal
2024-15.79%6.25%-17.65%-28.57%-30.00%14.29%-12.50%14.29%-57.89%
2023-4.03%-7.56%27.27%-25.00%4.76%-22.73%5.88%5.56%21.05%4.35%-20.83%-0.00%-23.39%
2022-18.35%-0.00%4.12%-13.66%-20.41%-34.29%39.04%0.00%9.46%0.00%-17.29%-13.59%-58.25%
2021-4.54%-13.33%6.32%-26.68%5.96%-14.29%-8.25%-5.50%17.28%-0.00%-8.11%7.03%-41.42%
2020-4.54%-23.81%100.00%-32.81%-13.93%-45.96%19.96%-8.32%4.54%-13.02%-1.95%12.17%-50.00%
2019-12.51%10.18%-18.52%-11.34%-5.12%-5.39%22.80%-0.00%9.33%-12.78%29.26%-16.99%-21.46%
2018-0.98%2.99%-9.61%5.31%-0.00%-5.04%-13.84%-3.70%-5.14%-12.14%-7.71%-6.65%-45.09%
201715.37%6.67%15.62%-21.62%-10.34%-3.86%-3.99%0.00%4.16%-15.99%-9.53%34.19%-1.94%
2016-16.67%-0.00%-14.99%23.54%28.56%22.21%6.06%-11.42%6.44%0.00%-12.11%-10.34%8.34%
2015-3.86%0.00%-8.00%8.70%-8.00%30.44%26.66%-15.78%-9.37%6.90%-16.13%-7.70%-7.70%
201410.34%0.00%-9.37%0.00%-20.70%13.06%11.53%3.44%-6.67%-10.71%12.00%-7.13%-10.34%
201340.02%52.36%6.25%-11.77%-10.00%-11.11%16.65%3.58%-6.90%59.25%-20.92%-14.70%93.35%

Risk-Adjusted Performance

Risk-Adjusted Performance Rank

The current rank of AN1.AX is 26, suggesting that the investment has average results relative to other stocks in terms of risk-adjusted performance. This ranking is determined by the cumulative values of the indicators listed below.


The Risk-Adjusted Performance Rank of AN1.AX is 2626
AN1.AX (Anagenics Limited)
The Sharpe Ratio Rank of AN1.AX is 2424Sharpe Ratio Rank
The Sortino Ratio Rank of AN1.AX is 3030Sortino Ratio Rank
The Omega Ratio Rank of AN1.AX is 3030Omega Ratio Rank
The Calmar Ratio Rank of AN1.AX is 1818Calmar Ratio Rank
The Martin Ratio Rank of AN1.AX is 2727Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

Risk-Adjusted Performance Indicators

The charts below present risk-adjusted performance metrics for Anagenics Limited (AN1.AX) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.


AN1.AX
Sharpe ratio
The chart of Sharpe ratio for AN1.AX, currently valued at -0.46, compared to the broader market-4.00-2.000.002.00-0.46
Sortino ratio
The chart of Sortino ratio for AN1.AX, currently valued at -0.11, compared to the broader market-6.00-4.00-2.000.002.004.00-0.11
Omega ratio
The chart of Omega ratio for AN1.AX, currently valued at 0.98, compared to the broader market0.501.001.500.98
Calmar ratio
The chart of Calmar ratio for AN1.AX, currently valued at -0.53, compared to the broader market0.001.002.003.004.005.00-0.53
Martin ratio
The chart of Martin ratio for AN1.AX, currently valued at -1.01, compared to the broader market-10.000.0010.0020.00-1.01
^GSPC
Sharpe ratio
The chart of Sharpe ratio for ^GSPC, currently valued at 2.10, compared to the broader market-4.00-2.000.002.002.10
Sortino ratio
The chart of Sortino ratio for ^GSPC, currently valued at 2.82, compared to the broader market-6.00-4.00-2.000.002.004.002.82
Omega ratio
The chart of Omega ratio for ^GSPC, currently valued at 1.38, compared to the broader market0.501.001.501.38
Calmar ratio
The chart of Calmar ratio for ^GSPC, currently valued at 1.88, compared to the broader market0.001.002.003.004.005.001.88
Martin ratio
The chart of Martin ratio for ^GSPC, currently valued at 11.08, compared to the broader market-10.000.0010.0020.0011.08

Sharpe Ratio

The current Anagenics Limited Sharpe ratio is -0.46. This value is calculated based on the past 1 year of trading data and takes into account price changes and dividends.

Use the chart below to compare the Sharpe ratio of Anagenics Limited with the selected benchmark, providing insights into the investment's historical performance in terms of risk-adjusted returns. Go to the Sharpe ratio tool for more fine-grained control over the calculation options.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00AprilMayJuneJulyAugustSeptember
-0.46
1.85
AN1.AX (Anagenics Limited)
Benchmark (^GSPC)

Dividends

Dividend History


Anagenics Limited doesn't pay dividends

Drawdowns

Drawdowns Chart

The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%AprilMayJuneJulyAugustSeptember
-99.90%
-1.21%
AN1.AX (Anagenics Limited)
Benchmark (^GSPC)

Worst Drawdowns

The table below displays the maximum drawdowns of the Anagenics Limited. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.

The maximum drawdown for the Anagenics Limited was 99.93%, occurring on Jun 13, 2024. The portfolio has not yet recovered.

The current Anagenics Limited drawdown is 99.90%.


Depth

Start

To Bottom

Bottom

To Recover

End

Total

-99.93%Mar 29, 20063753Jun 13, 2024
-23.08%Dec 12, 20056Dec 20, 200519Jan 27, 200625
-22.86%Mar 1, 20067Mar 10, 20063Mar 15, 200610
-9.76%Feb 13, 20063Feb 15, 20065Feb 22, 20068
-6.98%Mar 24, 20061Mar 24, 20061Mar 27, 20062

Volatility

Volatility Chart

The current Anagenics Limited volatility is 13.35%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.


0.00%10.00%20.00%30.00%40.00%50.00%AprilMayJuneJulyAugustSeptember
13.35%
3.12%
AN1.AX (Anagenics Limited)
Benchmark (^GSPC)

Financials

Financial Performance

The chart below illustrates the trends in the financial health of Anagenics Limited over time, highlighting three key metrics: Total Revenue, Earnings Before Interest and Taxes (EBIT), and Net Income.

Annual
Quarterly

0.0

Historical P/E Ratio Chart

The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Anagenics Limited.


Loading data...

Income Statement


Income Statement
Balance Sheet
Cash Flow
Annual
Quarterly

TTM
Revenue

Total Revenue

Cost Of Revenue

Gross Profit

Operating Expenses

Selling, General & Admin Expenses

R&D Expenses

Depreciation And Amortization

Total Operating Expenses

Income

Income Before Tax

Operating Income

EBITDA

EBIT

Earnings From Continuing Operations

Net Income

Income Tax Expense

Other Non-Operating Income (Expenses)

Extraordinary Items

Discontinued Operations

Effect Of Accounting Charges

Non Recurring

Minority Interest

Other Items

Interest Income

Interest Expense

Net Interest Income

Values in undefined except per share items